Patton Fund Management, Inc. Edwards Lifesciences Corp Transaction History

Patton Fund Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 08, 2020	SELL	$57.54 - $76.95 $226,707 - $303,183	-3,940 Closed	0 $0
Q1 2020 Apr 15, 2020	SELL	$52.41 - $81.0 $648,783 - $1 Million	-12,379 Reduced 75.86%	3,940 $743,000
Q4 2019 Jan 24, 2020	BUY	$71.7 - $82.09 $5,664 - $6,485	79 Added 0.49%	16,319 $3.81 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $193,020 - $236,548	-3,136 Reduced 16.18%	16,240 $3.57 Million
Q2 2019 Aug 09, 2019	BUY	$55.74 - $64.41 $1.08 Million - $1.25 Million	19,376 New	19,376 $3.58 Million

1,418

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Patton Fund Management, Inc. with notifications on news.